Risks of anticoagulation discontinuation after first venous thromboembolism in inherited thrombophilia: a long-term cohort study
Sang-A Kim, Sin Young Park, Ji Yun Lee, Junshik Hong, Sang-Hoon Na, Jeong-Ok Lee, Soo-Mee Bang · 2026
Read Risks of anticoagulation discontinuation after first venous thromboembolism in inherited thrombophilia: a long-term cohort study by Sang-A Kim, Sin Young Park, Ji Yun Lee, Junshik Hong, Sang-Hoon Na, Jeong-Ok Lee, Soo-Mee Bang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13425827.txt.
Description
Sang-A Kim and coauthors followed patients with inherited thrombophilia after a first venous thromboembolism in a 2026 long-term cohort study. Guidelines usually advise indefinite blood thinning when protein S, protein C, or antithrombin deficiency is present, yet direct comparisons of stopping versus continuing were scarce. Their retrospective cohort held 103 patients treated between 1987 and 2023, with 49 continuing therapy and 54 stopping.
Median age was 39 years and follow-up centered on six years, tracking recurrent clots and major bleeding as the main outcomes. Long-term data of this kind help patients weigh clot prevention against bleeding harm.
Catalog record
| CREATOR | Sang-A Kim, Sin Young Park, Ji Yun Lee, Junshik Hong, Sang-Hoon Na, Jeong-Ok Lee, Soo-Mee Bang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29343 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |